LNPs work by encapsulating cancer drugs or genetic materials within a lipid bilayer, which protects the payload from degradation and facilitates its delivery to the tumor site. Upon reaching the target, these nanoparticles can fuse with the cancer cell membrane, releasing the encapsulated therapeutic agent directly into the cell. This targeted delivery system increases the concentration of the drug within the tumor, minimizing side effects on healthy tissues.
